Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026

Go back to Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026
(NASDAQ: VYGR) Delayed: 3.09 +0.05 (1.64%)
Previous Close $3.04    52 Week High $30.54 
Open $3.01    52 Week Low $8.12 
Day High $3.11    P/E N/A 
Day Low $3.00    EPS $0.00 
Volume 538,083